tiprankstipranks
Trending News
More News >
Carisma Therapeutics (CARM)
OTHER OTC:CARM
US Market

Carisma Therapeutics (CARM) Income Statement

Compare
1,727 Followers

Carisma Therapeutics Income Statement

Last quarter (Q3 2025), Carisma Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Carisma Therapeutics's net income was $44.72M. See Carisma Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 19.63M$ 14.92M$ 9.83M$ 26.54M$ 11.24M
Gross Profit
$ -40.04M$ -59.21M$ 9.83M$ 26.46M$ 11.24M
Operating Expenses
$ 22.14M$ 29.52M$ 66.00M$ 54.62M$ 28.38M
Depreciation and Amortization
$ 3.35M$ 2.84M$ 1.89M$ 85.00K$ 122.00K
EBITDA
$ -56.83M$ -85.89M$ -56.19M$ -8.52M$ -27.93M
Operating Income
$ -62.18M$ -88.73M$ -56.16M$ -28.16M$ -28.38M
Other Income/Expenses
$ 1.70M$ 1.85M$ -5.06M$ 19.55M$ 29.00K
Pretax Income
$ -60.48M$ -86.88M$ -61.23M$ -8.61M$ -28.35M
Net Income
$ -60.48M$ -86.88M$ -61.23M$ -336.00K$ -28.35M
Per Share Metrics
Basic EPS
$ -1.46$ -2.59$ -1.52$ -1.01$ -0.70
Diluted EPS
$ -1.46$ -2.59$ -1.52$ -1.01$ -0.70
Weighted Average Shares Outstanding
41.46M 33.52M 40.26M 9.12M 5.91M
Weighted Average Shares Outstanding (Diluted)
41.46M 33.52M 40.26M 9.12M 5.91M
Currency in USD

Carisma Therapeutics Earnings and Revenue History